Giorgio Gimelli, MD
Interventional Cardiology · Madison, WINPI 1629044706
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,408 of the $4,772 with a category attached, or 71.4%. Abbott accounts for 95.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $3,260 and has fallen 85.4% since, to $477 in 2025.
Across 31 payments — averaging $153.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Edwards Lifesciences$146
- Medtronic$34
- Shockwave Medical, Inc$25
Across 59 payments — averaging $1230.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$67K
- Boston Scientific$3K
- W. L. Gore & Associates, Inc.$2K
What the payments were for
- Travel & lodging$3,40871%
- Food & beverage$1,36429%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 26 | $4,567 |
| Edwards Lifesciences | 2 | $146 |
| Medtronic | 2 | $34 |
| Shockwave Medical, Inc | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,772 in reported general payments places this provider in the 55th percentile of 118 interventional cardiology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 67 | $53,797 |
| Amlodipine Besylate | 164 | $930 |
| Metoprolol Succinate | 41 | $823 |
| ClopidogrelClopidogrel Bisulfate | 55 | $720 |
| Atorvastatin Calcium | 80 | $589 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 27 | $367 |
| Rosuvastatin Calcium | 24 | $318 |
| Carvedilol | 27 | $273 |
| Furosemide | 23 | $88 |
| Lisinopril | 27 | $69 |
| Losartan Potassium | 16 | $44 |
| Spironolactone | 11 | $40 |
| Amoxicillin | 34 | $37 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Madison
- Kurt JacobsonMadison$24K
- Amish RavalMadison$21K
- James BallardMadison$8K
- Alexandra ErdmannMadison$7K
- Benjamin CiskeMadison$5K
- Michael SalingerMilwaukee$216K
- Arun KalyanasundaramMarshfield$201K
- Michael RosenbergManitowoc$111K
- Tanvir BajwaMilwaukee$106K
- Suhail AllaqabandMilwaukee$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.